ArticleClinical kidney journal2012

Eculizumab in atypical haemolytic-uraemic syndrome allows cessation of plasma exchange and dialysis.

Jon Jin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.